HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by Akhter, S. A. Articles by Liggett, S. B. Search for Related Content PubMed PubMed Citation Articles by Akhter, S. A. Articles by Liggett, S. B.

Myocardial ₁-adrenergic receptor polymorphisms affect functional recovery after ischemic injury

¹Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio; and ²Cardiopulmonary Genomics Program, University of Maryland School of Medicine, Baltimore, Maryland

Submitted 23 August 2005 ; accepted in final form 3 November 2005

Association studies suggest ₁-adrenergic receptor (₁-AR) polymorphisms are disease modifiers in heart failure. The Arg389 variant has increased coupling to G_s in transfected cells and evokes enhanced ventricular function in transgenic mice. Here, we assessed the differential effects of the human Gly389 and Arg389 ₁-AR polymorphisms on myocardial recovery after ischemic injury. Function was studied in transgenic mice with cardiac-specific expression of either human Gly389 or Arg389 ₁-AR at baseline and after 20 min of ex vivo ischemia and reperfusion (I/R). In 3-mo-old mice of either genotype, there was poor recovery after I/R (38% vs. 68% for nontransgenic). Paradoxically, at 6 mo of age, functional recovery remained severely depressed in Gly389 hearts (32%) but was similar to nontransgenic for Arg389 hearts (60%). In Arg389 hearts, agonist-promoted adenylyl cyclase activities were depressed by 35% at 6 mo of age, and G protein-coupled receptor kinase (GRK) activity was increased by approximately twofold compared with Gly389. Furthermore, I/R evoked an approximately threefold increase in ERK2 phosphorylation in Arg389 but an approximately twofold decrease in Gly389 hearts. Individually, these changes have been shown to mitigate I/R injury; thus the Arg389-₁-AR uniquely evokes specialized pathways that act to protect against I/R injury. The improved recovery of function after I/R in Arg389 hearts relative to Gly389 appears to be due to an adaptive multimechanism program with allele-specific alterations in receptor signaling, GRK activity, and ERK2. Thus genetic variation of the human ₁-AR may play a role in cardiac functional recovery after ischemic injury.

genetics; adenylyl cyclase; mitogen-activated protein kinase; G protein-coupled receptor kinase

This article has been cited by other articles:

				M. J. London Quo Vadis, Perioperative Beta Blockade? Are You "POISE'd" on the Brink? Anesth. Analg., April 1, 2008; 106(4): 1025 - 1030. [Full Text] [PDF]

				A. Muthumala, F. Drenos, P. M. Elliott, and S. E. Humphries Role of {beta} adrenergic receptor polymorphisms in heart failure: Systematic review and meta-analysis Eur J Heart Fail, January 1, 2008; 10(1): 3 - 13. [Abstract] [Full Text] [PDF]

				S. T. Pleger and W. J. Koch The yin and yang of increased beta-adrenergic signaling: beta1-adrenergic genetic polymorphism and protection against acute myocardial ischemic injury Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1408 - H1409. [Full Text] [PDF]